Theravance Biopharma, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Theravance Biopharma, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2013 to Q4 2024.
  • Theravance Biopharma, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2024 was $83.7M, a 5.27% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $83.7M +$4.19M +5.27% Dec 31, 2024 10-K 2025-03-07
Q4 2023 $79.5M +$3.47M +4.57% Dec 31, 2023 10-K 2025-03-07
Q4 2022 $76M +$976K +1.3% Dec 31, 2022 10-K 2025-03-07
Q3 2022 $62.7M Sep 30, 2022 10-Q 2022-11-09
Q4 2021 $75M +$11.6M +18.2% Dec 31, 2021 10-K 2024-03-01
Q4 2020 $63.4M +$4.68M +7.97% Dec 31, 2020 10-K 2023-03-01
Q4 2019 $58.8M +$6.36M +12.1% Dec 31, 2019 10-K 2022-02-28
Q4 2018 $52.4M +$10.6M +25.4% Dec 31, 2018 10-K 2021-02-26
Q4 2017 $41.8M +$18.5M +79.7% Dec 31, 2017 10-K 2020-02-27
Q4 2016 $23.3M +$14.1M +153% Dec 31, 2016 10-K 2019-02-28
Q4 2015 $9.2M +$8.14M +769% Dec 31, 2015 10-K 2018-02-28
Q3 2015 $2.4M +$2M +500% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $1.9M +$1.9M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $1.4M Mar 31, 2015 10-Q 2015-05-13
Q4 2014 $1.06M +$1.02M Dec 31, 2014 10-K 2017-03-01
Q3 2014 $400K Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $0 Jun 30, 2014 10-Q 2014-08-14
Q4 2013 $41K* Dec 31, 2013 10-K 2017-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.